Reviewing meds with a pharmacist may boost adherence

Engaging Medicare members associated with improved adherence: Part of the Star rating composite score

How well do medication management therapy (MTM) programs work? This study showed that members who completed comprehensive medication reviews (CMRs), as part of a MTM program, improved the percentage of adherent members. 40% more members were adherent. (Adherence was defined as having a proportion of days covered over 80%.) Adherence was measured for medications to treat diabetes, high blood pressure and high cholesterol.

Medication Therapy Management (MTM) Comprehensive Medication Review (CMR) Impact Assessment (Fall 2015)

About Prime Therapeutics

Prime Therapeutics LLC (Prime) is a diversified pharmacy solutions organization serving health plans, employers and government programs. Prime is collectively owned by 19 Blue Cross and Blue Shield Plans, subsidiaries or affiliates of those plans. Magellan Rx Management, a Prime Therapeutics LLC Company, is a pioneer in specialty and medical drug management and a leader in serving public sector state government programs. Together Prime and Magellan Rx provide a wide range of clients with solutions that bridge the distance between medical and pharmacy management. For more information visit www.primetherapeutics.com and www.magellanrx.com, or follow us on Twitter at @Prime_PBM and @Magellan_Rx.

Reviewing meds with a pharmacist may boost adherence

Engaging Medicare members associated with improved adherence: Part of the Star rating composite score

Medication Therapy Management (MTM) Comprehensive Medication Review (CMR) Impact Assessment (Fall 2015)

About Prime Therapeutics

Related news

Specialty Drug Pipeline Quarterly Update: September 2023

Traditional Drug Pipeline Quarterly Update: September 2023

Gene/Cell Therapy Quarterly Update: September 2023